scholarly journals Diagnosis, Background, and Treatment of Hypothalamic Damage in Craniopharyngioma

2020 ◽  
Vol 110 (9-10) ◽  
pp. 767-779 ◽  
Author(s):  
Eva-Marie Erfurth
Keyword(s):  
Hypothalamic Damage

Sensory Neglect Produced by Lateral Hypothalamic Damage

Science ◽  
1971 ◽  
Vol 174 (4008) ◽  
pp. 523-525 ◽  
Author(s):  
J. F. Marshall ◽  
B. H. Turner ◽  
P. Teitelbaum
Keyword(s):  
Lateral Hypothalamic ◽  
Sensory Neglect ◽  
Hypothalamic Damage

Microstructure alterations in the hypothalamus in cranially radiated childhood leukaemia survivors but not in craniopharyngioma patients unaffected by hypothalamic damage

2017 ◽  
Vol 87 (4) ◽  
pp. 359-366 ◽  
Author(s):  
Cecilia Follin ◽  
Sigridur Fjalldal ◽  
Daniel Svärd ◽  
Danielle van Westen ◽  
Sanaz Gabery ◽  
...  
Keyword(s):  
Childhood Leukaemia ◽  
Hypothalamic Damage

Relation between medial hypothalamic damage and impairments in regulation of sodium intake

1969 ◽  
Vol 4 (1) ◽  
pp. 101-103 ◽  
Author(s):  
David Quartermain ◽  
George Wolf ◽  
John Keselica
Keyword(s):  
Sodium Intake ◽  
Hypothalamic Damage

Enhanced release of striatal dopamine following medial hypothalamic damage in rats

Life Sciences ◽  
1977 ◽  
Vol 20 (8) ◽  
pp. 1377-1382 ◽  
Author(s):  
John F. Marshall ◽  
Seymour M. Antelman ◽  
Neil E. Rowland ◽  
David J. Edwards
Keyword(s):  
Striatal Dopamine ◽  
Hypothalamic Damage

scholarly journals Endocrine aspects and sequel in patients with craniopharyngioma

2015 ◽  
Vol 28 (1-2) ◽  
Author(s):  
Eva Marie Erfurth
Keyword(s):  
Bone Health ◽  
Neurological Deficits ◽  
Pituitary Tumours ◽  
Cranial Radiotherapy ◽  
Parasellar Region ◽  
Hypothalamic Damage ◽  
Visual Disturbances ◽  
Overall Mortality

AbstractA craniopharyngioma (CP) is an embryonic malformation of the sellar and parasellar region. The annual incidence is 0.5–2.0 cases/million per year and approximately 60% of CP is seen in adulthood. The therapy of choice is surgery, followed by cranial radiotherapy in about half of the patients. Typical initial manifestations at diagnosis in children are symptoms of elevated intracranial pressure, visual disturbances and hypopituitarism. CPs have the highest mortality of all pituitary tumours. The standardised overall mortality rate varies from 2.88 to 9.28 in cohort studies. Adults with CP have a 3–19-fold higher cardiovascular mortality in comparison to the general population. Women with CP have an even higher risk. The long-term morbidity is substantial with hypopituitarism, increased cardiovascular risk, hypothalamic damage, visual and neurological deficits, reduced bone health and reduction in quality of life and cognitive function.

Sign in / Sign up

Export Citation Format

Share Document